Heterocyclic sulfonamide derivatives

Details for Australian Patent Application No. 2010329940 (hide)

Owner Novartis AG

Inventors Bock, Mark G.; Chikkanna, Dinesh; McCarthy, Clive; Moebitz, Henrik; Pandit, Chetan; Poddutoori, Ramulu

Agent Davies Collison Cave

Pub. Number AU-A-2010329940

PCT Pub. Number WO2011/070030

Priority 3019/CHE/09 08.12.09 IN

Filing date 7 December 2010

Wipo publication date 16 June 2011

International Classifications

C07D 263/56 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 307/79 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/070030 Priority application(s): WO2011/070030

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010329947-A bale cutting apparatus and method

2010329934-Antibodies binding preferentially human CSF1R extracellular domain 4 and their use